Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
7
A nationwide study from Denmark presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey, shows that use of semaglutide (Wegovy) for weight management is associated with a 7% reduction in the use of triptan-class ...
May 15, 2026
0
7
Body mass index (BMI) is a simple mathematical formula widely used to quickly gauge someone's health. BMI = weight (kg) divided by height squared (m2). Its simplicity and cost-effectiveness makes BMI a popular health tool, ...
May 10, 2026
0
7
As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.
May 5, 2026
0
7
Consumption of ultra-processed foods—including soft drinks, snacks and ready meals—is growing worldwide, despite evidence they are unhealthy.
May 1, 2026
0
7
People with severe obesity who exercise regularly have healthier blood vessels and lower inflammation than those who rely on medication alone, a new study from the University of Copenhagen shows.
Jul 8, 2026
0
7
Heart failure already affects more than 60 million people worldwide and is one of the leading causes of hospitalization among people 65 and older. Although it is commonly associated with advanced cardiovascular disease, it ...
Jul 21, 2026
0
7
As the use of GLP-1 medications for weight loss surges, so do calls to U.S. poison control centers, according to a new study.
Jun 25, 2026
0
7
Two related studies published recently by international teams—including researchers with the UCLA Fielding School of Public Health and the UCLA Joe C. Wen School of Nursing—examined how diabetes, heart disease and other chronic ...
Mar 17, 2026
0
7
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes ...
Jul 9, 2026
0
7
